Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline    GSK   GB0009252882

GLAXOSMITHKLINE (GSK)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Sales23 00623 92327 88930 09230 53831 410
EBITDA8 0457 0289 63210 29510 22010 552
Operating profit (EBIT)6 5945 7297 7718 4418 3348 721
Pre-Tax Profit (EBT)2 96810 5261 9395 5726 4406 874
Net income2 7568 4229123 7214 2304 653
P/E ratio24,37,9783,118,114,813,5
EPS (GBp )56,717218,871,987,696,3
Dividend per Share (GBp )80,080,080,080,080,080,2
Yield5,81%5,83%5,12%6,17%6,17%6,18%
Reference price (GBp )1376137315621297.51297.51297.5
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Debt14 37710 72713 80414 27914 02813 486
Finance------
Operating income (EBITDA)8 0457 0289 63210 29510 22010 552
Leverage
(Debt/EBITDA)
1,79x1,53x1,43x1,39x1,37x1,28x
Capital Expenditure1 1881 3801 5431 7631 7281 777
Book Value Per Share (BVPS)87,6 PNC106 PNC22,9 PNC25,1 PNC41,7 PNC65,2 PNC
Cash Flow per Share108 PNC53,2 PNC132 PNC133 PNC139 PNC147 PNC
Announcement Date02/04/2015
03:18pm
02/03/2016
12:00pm
02/08/2017
12:35pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 63 820 M GBP -
Entreprise Value (EV) 78 099 M GBP 77 848 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 18,1x 14,8x
Capitalization / Revenue 2,12x 2,09x
EV / Revenue 2,60x 2,55x
EV / EBITDA 7,59x 7,62x
Yield (DPS / Price) 6,17% 6,17%
Price to book (Price / BVPS) 51,6x 31,1x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 28,1% 27,3%
operating Leverage (Delta EBIT / Delta Sales) 1,09x -
Net Margin (Net Profit / Revenue) 12,4% 13,9%
ROA (Net Profit / Asset) 8,71% 9,57%
ROE (Net Profit / Equities) 492% 279%
Rate of Dividend 111% 91,4%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   5,86% 5,66%
Cash Flow / Sales 21,7% 22,5%
Capital Intensity (Assets / Sales) 1,42x 1,45x
Financial Leverage (Net Debt / EBITDA) 1,39x 1,37x
EPS & Dividend